People · Operator

David Colaizzi

Named in public records as an officer, director or promoter · active 2022–2022 · Other, Biotechnology

2
Companies
2
Filings
$25.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Maitri Holdings, LLCOtherSeries B$23.8M$168.2M2022
BioHybrid Solutions Holdings, Inc.BiotechnologySeed$1.5M$25.6M2022
Operator network

David Colaizzi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

John Mazarakis · 4 companies · 1 sharedJohn MazarakisAndreas Bodmeier · 2 companies · 1 sharedAndreas BodmeierCorinne Ogrodnik · 2 companies · 1 sharedCorinne OgrodnikJimil Wilson · 2 companies · 1 sharedJimil WilsonJoseph Vesely · 2 companies · 1 sharedJoseph VeselyDerrick Hawthorne · 1 companies · 1 sharedDerrick HawthorneJessica Brooks · 1 companies · 1 sharedJessica BrooksKrzysztof Matyjaszewski · 2 companies · 1 sharedKrzysztof Matyjas…Patrick Bailey · 2 companies · 1 sharedPatrick BaileyAntonina Simakova · 1 companies · 1 sharedAntonina SimakovaAutumn Gindlesberger · 1 companies · 1 sharedAutumn Gindlesber…Jean Pineault · 1 companies · 1 sharedJean PineaultMaitri Holdings, LLC · $23.8M raisedMaitri Holdings, LLCBioHybrid Solutions Holdings, Inc. · $1.5M raisedBioHybrid Solutions H…David ColaizziDC
David Colaizzi Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David Colaizzi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
John Mazarakis14
Jimil Wilson12
Patrick Bailey12
Andreas Bodmeier12
Krzysztof Matyjaszewski12
Corinne Ogrodnik12
Joseph Vesely12
Autumn Gindlesberger11
Jessica Brooks11
Derrick Hawthorne11
Jean Pineault11
Antonina Simakova11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.